Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Kidney Transplant Recipients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00693446
What this trial is testing

Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids

Who this might be right for
Pancreas TransplantationKidney Transplantation
Nantes University Hospital 118
Large-scale testing (Phase 3)Study completedNCT00149903
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients

Who this might be right for
Renal Transplant
Novartis Pharmaceuticals 300
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06751602
What this trial is testing

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Rejection Chronic Renal
The Methodist Hospital Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT01064791
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 298
Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Large-scale testing (Phase 3)Study completedNCT03507829
What this trial is testing

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

Who this might be right for
Hyperglycemia
Medical University of Vienna 263
Testing effectiveness (Phase 2)Study completedNCT00492869
What this trial is testing

Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 124
Post-approval studies (Phase 4)Study completedNCT02084446
What this trial is testing

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

Who this might be right for
Transplantation InfectionCytomegalovirus Infections
Ronaldo de Matos Esmeraldo, MD 120
Large-scale testing (Phase 3)Study completedNCT01025817
What this trial is testing

Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 613
Large-scale testing (Phase 3)Study completedNCT00064701
What this trial is testing

Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 668
Large-scale testing (Phase 3)Study completedNCT00248313
What this trial is testing

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney Disease
Wyeth is now a wholly owned subsidiary of Pfizer 470
Not applicableStudy completedNCT01496417
What this trial is testing

Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores

Who this might be right for
End-Stage Renal Disease
University of Maryland 20
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Large-scale testing (Phase 3)UnknownNCT02314312
What this trial is testing

Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors

Who this might be right for
Transplantation of KidneyExpanded Criteria DonorECD
Mahidol University 48
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01614665
What this trial is testing

Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 44
Post-approval studies (Phase 4)Study completedNCT01371331
What this trial is testing

Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Who this might be right for
Kidney TransplantationHeart TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 52
Large-scale testing (Phase 3)Study completedNCT00239031
What this trial is testing

Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids

Who this might be right for
Denovo Renal Transplantation
Novartis 117
Not applicableStudy completedNCT01265537
What this trial is testing

A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf

Who this might be right for
Acute Graft RejectionDiabetes
University of British Columbia 30
Large-scale testing (Phase 3)Ended earlyNCT01442337
What this trial is testing

Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 21
Next Page